Evidence map›Paper›PMID 36438695›Full record

ArticleInfectious Disease Modelling2022

The distribution of COVID-19 mortality.

Michele Campolieti, Arturo Ramos

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michele CampolietiDepartment of Management, University of Toronto Scarborough, Toronto, Canada.
Arturo RamosDepartamento de Análisis Económico, Universidad de Zaragoza, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We estimate the distribution of COVID-19 mortality (measured as daily deaths) from the start of the pandemic until July 31st, 2022, for six European countries and the USA. We use the Pareto, the stretched exponential, the log-normal and the log-logistic distributions as well as mixtures of the log-normal and log-logistic distributions. The main results are that the Pareto does not describe well the data and that mixture distributions tend to offer a very good fit to the data. We also compute Value-at-Risk measures as well as mortality probabilities with our estimates. We also discuss the implications of our results and findings from the point of view of public health planning and modelling.

Indexed as

COVID-19Log-normal and log-logistic distributionsMixture distributionsMortality distributionParetoStretched exponentialTail risksValue-at-Risk measures

Identifiers

PMID36438695
PMCPMC9674562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.